| Case Page

 | Case Page |

Case Page

 

Vascular Solutions, Inc.

Case Summary

Vascular Solutions, Inc. Securities Litigation

Case Summary

Case Status:    DISMISSED    
On or around 02/17/2017 (Court's order of dismissal)

Filing Date: January 27, 2017

According to the Complaint, on December 1, 2016, Vascular Solutions’ Board of Directors (the “Board” or “Individual Defendants”) caused the Company to enter into an agreement and plan of merger (the “Merger Agreement”). Pursuant to the terms of the Merger Agreement, shareholders of Vascular Solutions will receive $56.00 per share in cash.

On January 18, 2017, defendants filed a proxy statement (the “Proxy Statement”) with the United States Securities and Exchange Commission (“SEC”) in connection with the Proposed Transaction.

The Complaint alleges the Proxy Statement omits material information with respect to the Proposed Transaction, which renders the Proxy Statement false and misleading.

This case was voluntarily dismissed on February 17, 2017.

Company & Securities Information

Defendant: Vascular Solutions, Inc.

COMPANY INFORMATION:

Sector: Healthcare
Industry: Medical Equipment & Supplies
Headquarters: United States

SECURITIES INFORMATION:

Ticker Symbol: VASC
Company Market: NASDAQ
Market Status: Public (Listed)

About the Company & Securities Data


"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.

In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.

First Identified Complaint

Paul Parshall, et al. v. Vascular Solutions, Inc., et al.

COURT: D. Minnesota
DOCKET #: 17-CV-00272
JUDGE: Hon. Donovan W. Frank
DATE FILED: 01/27/2017
CLASS PERIOD START: 12/02/2016
CLASS PERIOD END: 01/27/2017
PLAINTIFF FIRMS NAMED IN COMPLAINT:
  1. Lockridge Grindal Nauen P.L.L.P.
    100 Washington Avenue S. Suite 2200, Lockridge Grindal Nauen P.L.L.P., MN 55401
    612.339.6900 612.339.6900 ·
  2. Rigrodsky & Long, P.A.
    919 N. Market Street, Suite 980, Rigrodsky & Long, P.A., DE 19803
    302.295.5310 302.295.5310 · info@rigrodskylong.com
  3. RM Law, P.C.
    1055 Westlakes Drive, Suite 3112, RM Law, P.C., PA 19312
    (484) 324-6800 ·
First Identified Complaint (FIC) Filings:
No Document Title Filing Date
1 Complaint for Violation of the Securities Exchange Act of 1934 01/27/2017
2 Plaintiff's Notice of Voluntary Dismissal 02/17/2017
3 Order for Dismissal without Prejudice 02/17/2017
4 U.S. District Court Civil Docket 02/17/2017
 
 

Cases